MAM
AXSM icon

Marquette Asset Management’s Axsome Therapeutics AXSM Stock Holding History

Marquette Asset Management’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$980 Hold
4
– – ﹤0.01% 731
2026
Q1 		$677 Hold
4
– – ﹤0.01% 710
2025
Q4 		$731 Buy
+4
New +$558 ﹤0.01% 592

Other funds holding AXSM

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
BWP
Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
TAM
Tealwood Asset Management Minneapolis, Minnesota $261M AUM 52.68% 1-Year Est. Return
CA
Cannon Advisors Charlotte, North Carolina $164M AUM 30.34% 1-Year Est. Return
MCP
Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return

Marquette Asset Management's AXSM Position: Q2 2026 in Review

Marquette Asset Management held its Axsome Therapeutics (AXSM) position steady in Q2 2026 at 4 shares worth $980. The position accounts for ﹤0.01% of the portfolio, ranked #731.

Marquette Asset Management first reported a position in AXSM in Q4 2025 and has held it in 3 quarters since. 38 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Marquette Asset Management held 4 shares of Axsome Therapeutics worth $980 as of Q2 2026.
  • Marquette Asset Management left its Axsome Therapeutics share count unchanged in Q2 2026.
  • Axsome Therapeutics made up ﹤0.01% of Marquette Asset Management's portfolio in Q2 2026, its #731 holding.
  • Marquette Asset Management first reported a position in Axsome Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 38 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Marquette Asset Management's 13F filing for Q2 2026, filed 9 Jul 2026.